Journal of Clinical Oncology

Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation

W Warren B. Fingrut (Warren B. Fingrut, MD, MPH, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Andromachi Scaradavou, MD, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY; and Juliet N. Barker, MBBS, Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY) A Andromachi Scaradavou (Warren B. Fingrut, MD, MPH, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Andromachi Scaradavou, MD, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY; and Juliet N. Barker, MBBS, Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY) J Juliet N. Barker (Warren B. Fingrut, MD, MPH, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Andromachi Scaradavou, MD, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY; and Juliet N. Barker, MBBS, Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 4
Published February 01, 2025
Pages 475-476
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (3)

W

Warren B. Fingrut

Warren B. Fingrut, MD, MPH, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Andromachi Scaradavou, MD, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY; and Juliet N. Barker, MBBS, Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY

A

Andromachi Scaradavou

Warren B. Fingrut, MD, MPH, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Andromachi Scaradavou, MD, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY; and Juliet N. Barker, MBBS, Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY

J

Juliet N. Barker

Warren B. Fingrut, MD, MPH, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Andromachi Scaradavou, MD, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY; and Juliet N. Barker, MBBS, Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001